The agreement requires Denmark-based manufacturer NovoNordisk to cap monthly out-of-pocket payments for insulin at $35 a month for the next five years, even for people without health insurance.
NovoNordisk (NVO) has reportedly settled a lawsuit filed by the state of Minnesota over the pricing of its insulin products by agreeing to cap costs at $35 per month. Under the settlement ...
Results that may be inaccessible to you are currently showing.